Clinical trial
7 Day Continuous Parathyroid Hormone IV Infusion
NCT00377312 · University of Pittsburgh, Other · Completed
Key facts
| NCT number | NCT00377312 |
|---|---|
| Title | 7 Day Continuous Parathyroid Hormone IV Infusion |
| Official title | Determining the Maximal Safe Dose of a Continuous Infusion of Parathyroid Hormone(1-34): Effects on Bone Formation |
| Lead sponsor | University of Pittsburgh, Other |
| Collaborators | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NIH |
| Status | Completed |
| Phase | Early Phase 1 |
| Study type | Interventional |
| Conditions | Osteoporosis, Bone Diseases, Endocrine, Hyperparathyroidism |
| Intervention type | Drug |
| Interventions | Parathyroid Hormone (1-34) |
| Enrollment | 11 |
| Start date | Sep 1, 2006 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Sep 18, 2006 |
| Last update posted | Mar 22, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: